571 results
Keyword EPAR Remove keyword
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11 to 14 September 2017
CHMP, Last updated: 15/09/2017Community reviews Adlumiz: EPAR Benlysta EPAR Cyltezo EPAR Elebrato Ellipta EPAR Firazyr … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 January 2020
CHMP, Last updated: 31/01/2020EMA/634510/2019 Generic Ameluz: EPAR Arsenic trioxide Mylan EPAR Azacitidine betapharm EPAR Azacitidine Mylan … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2016
CHMP, Last updated: 14/10/2016Review Group (NRG) Cystadrops: EPAR Emtricitabine/Tenofovir disoproxil … Emtricitabine/Tenofovir disoproxil Krka: EPAR Emtricitabine/Tenofovir disoproxil … Emtricitabine/Tenofovir disoproxil Mylan: EPAR Lucentis … -
List item
News: CHMP meets to discuss Avandia and Pandemrix
CHMP, Last updated: 08/09/2010Committee's conclusions. Pandemrix: EPAR Pandemrix: Paediatric investigation … Related information Avandia: EPAR Avaglim EPAR Avandamet EPAR Pandemrix … -
List item
News: CHMP meeting on 8 September 2010 to discuss Avandia and Pandemrix
CHMP, Last updated: 03/09/2010Pandemrix: EPAR Pandemrix: Paediatric investigation … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 December 2019
CHMP, Last updated: 13/12/201913/12/2019 Generic Akynzeo: EPAR Amsparity EPAR Azacitidine Accord EPAR Beovu EPAR Cyramza … -
List item
Press release: Factor VIII medicines: no clear and consistent evidence of difference in risk of inhibitor development between classes
CHMP, Last updated: 15/09/2017Advate: EPAR Elocta EPAR Helixate NexGen EPAR Iblias EPAR Kogenate Bayer … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 April 2018
CHMP, Last updated: 27/04/2018EMA/CHMP/SAWP/262775/2018 Generic Alsitek: EPAR Biktarvy EPAR Carmustine Obvius EPAR Cimzia … -
List item
Press release: Update on the withdrawal of Thelin
CHMP, Last updated: 16/12/2010Related information Thelin: EPAR Tracleer EPAR Volibris EPAR Thelin (sitaxentan) to be … injury (10/12/2010) Adcirca: EPAR Revatio … public assessment reports (EPARs) available on the Agency's … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 May 2017
CHMP, Last updated: 19/05/2017Community reviews Adlumiz: EPAR Blitzima EPAR Efavirenz/Emtricitabine/Tenofovir … Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva: EPAR Human IGG1 monoclonal antibody … interleukin-1 alpha XBiotech: EPAR Insulin lispro Sanofi … -
List item
Press release: European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines
CHMP, Last updated: 17/02/2012Riprazo: EPAR … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2019
CHMP, Last updated: 28/06/2019Generic Azacitidine Celgene: EPAR Cyramza EPAR Dupixent EPAR Ebymect EPAR Edistride … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2020
CHMP, Last updated: 24/07/2020Adakveo: EPAR Arikayce liposomal EPAR Arsenic trioxide medac EPAR Ayvakyt EPAR Blenrep … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 January 2016
CHMP, Last updated: 29/01/2016Amlodipine / Valsartan Mylan : EPAR Coagadex EPAR Dropcys EPAR Empliciti EPAR Rasagiline Mylan … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2020
CHMP, Last updated: 18/09/2020Deltyba: EPAR Elzonris EPAR Exparel liposomal EPAR Flucelvax Tetra EPAR Fycompa … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 April 2017
CHMP, Last updated: 21/04/2017Community reviews Avastin: EPAR Besponsa EPAR Brineura EPAR Celsentri EPAR Cuprior … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 October 2017
CHMP, Last updated: 13/10/2017PRIME scheme Alecensa: EPAR Bydureon EPAR Cubicin EPAR Faslodex EPAR Pegasys … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2020
CHMP, Last updated: 16/10/2020Blincyto: EPAR Desloratadine ratiopharm EPAR Dupixent EPAR Edistride EPAR Fintepla … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2016
CHMP, Last updated: 22/07/2016Organisational matters Ameluz: EPAR Cabometyx EPAR Imbruvica EPAR Inhixa EPAR Kisplyx … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 May 2016
CHMP, Last updated: 27/05/2016Organisational matters Adcetris: EPAR Bortezomib Hospira EPAR Bortezomib Sun EPAR Epclusa … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 September 2012
CHMP, Last updated: 21/09/2012Avastin: EPAR BindRen EPAR Cialis EPAR Eliquis EPAR Eucreas … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 28-30 April 2020
CHMP, Last updated: 30/04/2020EMA/CHMP/SAWP/232798/2020 Generic Braftovi: EPAR Cabazitaxel Accord EPAR Cablivi EPAR Carmustine Obvius … -
List item
Press release: European Medicines Agency clarifies opinion on pioglitazone and the risk of bladder cancer
CHMP, Last updated: 21/10/2011EMA/CHMP/847737/2011 Generic Actos: EPAR Competact EPAR Glubrava EPAR Glustin EPAR Tandemact … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 October 2013
CHMP, Last updated: 25/10/2013medical devices Brintellix: EPAR Cimzia EPAR Eviplera EPAR Levetiracetam Hospira EPAR Opsumit … -
List item
Press release: Update on ongoing European review of pioglitazone–containing medicines
CHMP, Last updated: 09/06/2011EMA/278128/2011 Generic Actos: EPAR Competact EPAR Glubrava EPAR Glustin EPAR Tandemact …